Myocardial disarray

Myocardial Disarray

Myocardial disarray, commonly known as myocyte disarray, refers to the pathological rearrangement of myocytes, the muscle cells responsible for the contractile function of the heart. In a healthy heart, these cells are aligned in a parallel fashion, enabling synchronized contractions. However, in cases of myocardial disarray, this regular alignment is lost, leading to myocytes that often encircle regions of connective tissue.

Pathogenesis

The precise mechanism causing myocardial disarray remains under investigation, but it's understood that this disorganized cellular arrangement can potentially interfere with the heart's electrical conductivity and contractility. Furthermore, myocardial disarray is often seen in conjunction with myocardial fibrosis, a process where these muscle cells are replaced with non-contractile scar tissue, further compromising the heart's function.

Associated Conditions

Several cardiac conditions and diseases have been identified where myocardial disarray is a prominent feature:

• Aortic stenosis: A narrowing of the aortic valve which can lead to increased pressure in the left ventricle.
• Congenital heart disease: Heart defects present at birth that can alter the heart's structure and function.
• Hypertensive heart disease: Changes to the heart muscle due to consistently elevated blood pressure.
• Hypertrophic cardiomyopathy: A genetic condition where the heart muscle becomes thickened without an apparent cause.

The unifying characteristic among these conditions is that they induce varying degrees of remodeling in the ventricles, especially in the form of myocardial fibrosis.

Clinical Implications

Given the potential for myocardial disarray to affect the heart's electrical system, there's an increased risk for arrhythmias in patients with this condition. Moreover, the presence of myocardial fibrosis can reduce the heart's ability to pump efficiently, leading to heart failure in advanced stages.

Diagnosis and Management

Advanced imaging techniques, including cardiac MRI, can help identify regions of disarray and fibrosis. Genetic testing, especially in cases of hypertrophic cardiomyopathy, can offer insights into potential inherited risks. Management typically focuses on treating the underlying condition, monitoring for complications, and providing symptomatic relief.

External links

• Myocardial disarray: A critical review from BMJ Journals
• Stanford Hypertrophic Cardiomyopathy Center

References

<references>

• Maron, B. J., & Maron, M. S. (2013). Hypertrophic cardiomyopathy. Lancet, 381(9862), 242-255.
• Basso, C., Thiene, G., Corrado, D., Buja, G., Melacini, P., & Nava, A. (2000). Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Human pathology, 31(8), 988-998.
• McKenna, W. J., & Sen-Chowdhry, S. (2008). Sudden cardiac death in the young: a strategy for prevention by targeted evaluation. Cardiology, 110(1), 11-19.

</references>

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

Sponsors (Advertise on WikiMD) <randomimage size="250" float="right" link="Main Page" choices="W8MD weight loss team.jpg|W8MD-ad4.jpg|W8md-weight-loss-logo.jpg|W8MD-Team.jpg|W8MD and WikiMD founder.jpg" /> W8MD weight loss, sleep and medspa centers

1. Pennsylvania - Philadelphia medical weight loss | Sleep doctor Philadelphia Call (215)676-2334
2. New York - NYC medical weight loss | Sleep apnea NYC Call (718)946-5500

Amazing testimonials
I would most definitely recommend to go here. They are very nice helpful and know what they are doing and talking about, I can see that the doctor has experience for sure. - A patient.

Portions of content adapted from Wikipedia's article on Myocardial disarray which is released under the CC BY-SA 3.0.